Home › Funds › Foresight Global Investors › NVS
Foresight Global Investors position in NVS
NOVARTIS AG · Health Care
Latest position (Q2 2026)153.69K sh
Reported value held$24.09M
Portfolio Weight14.60%
First reportedQ3 2023
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 97.50K | $9.40M | New |
| Q4 2023 | 131.97K | $13.33M | Add |
| Q1 2024 | 197.38K | $19.09M | Add |
| Q2 2024 | 171.30K | $18.24M | Reduce |
| Q3 2024 | 224.82K | $25.86M | Add |
| Q4 2024 | 232.37K | $22.61M | Add |
| Q1 2025 | 187.82K | $20.94M | Reduce |
| Q2 2025 | 164.92K | $19.96M | Reduce |
| Q3 2025 | 171.68K | $22.02M | Add |
| Q4 2025 | 172.08K | $23.73M | Hold |
| Q1 2026 | 172.05K | $26.28M | Hold |
| Q2 2026 | 153.69K | $24.09M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding NVS
- Morgan Stanley 8.73M sh · $1.37B · Q2 2026
- Bank of America Corp 4.91M sh · $769.49M · Q2 2026
- Franklin Resources 3.25M sh · $509.54M · Q2 2026
- BlackRock Inc 3.05M sh · $477.68M · Q2 2026
- Goldman Sachs Group 2.98M sh · $467.05M · Q2 2026
- Northern Trust Corp 2.79M sh · $437.68M · Q2 2026
- JPMorgan Chase & Co 2.26M sh · $356.85M · Q2 2026
- Janus Henderson Group 2.28M sh · $347.65M · Q1 2026
- Fidelity Management & Research (FMR) 2.06M sh · $322.44M · Q2 2026
- Wells Fargo & Co 1.83M sh · $286.61M · Q2 2026
- Principal Global Investors 1.57M sh · $245.39M · Q2 2026
- UBS Group AG 1.18M sh · $185.62M · Q2 2026